Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore. Issue 2 (March 2022)
- Record Type:
- Journal Article
- Title:
- Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore. Issue 2 (March 2022)
- Main Title:
- Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore
- Authors:
- Foo, Reuben
Yau, Christine
Singhal, Shweta
Tow, Sharon
Loo, Jing-Liang
Tan, Kevin
Milea, Dan - Abstract:
- Abstract: Purpose: The Optic Neuritis Treatment Trial was a landmark study with implications worldwide. In the advent of antibody testing for neuromyelitis optica spectrum disease (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), emerging concepts, such as routine antibody testing and management, remain controversial, resulting mostly from studies in White populations. We evaluate the practice patterns of optic neuritis investigation and management by neuro-ophthalmologists and neurologists in Singapore. Design: 21-question online survey consisting of 4 clinical vignettes. Methods: The survey was sent to all Singapore Medical Council– registered ophthalmologists and neurologists who regularly manage patients with optic neuritis. Results: Forty-two recipients (17 formally trained neuro-ophthalmol-ogists [100% response rate] and 25 neurologists) responded. Participants opted for routine testing of anti–aquaporin-4 antibodies (88.1% in mild optic neuritis and 97.6% in severe optic neuritis). Anti-MOG antibodies were frequently obtained (76.2% in mild and 88.1% in severe optic neuritis). Plasmapheresis was rapidly initiated (85.7%) in cases of nonresponse to intravenous steroids, even before obtaining anti–aquaporin-4 or anti-MOG serology results. In both NMOSD and MOGAD, oral mycophenolate mofetil was the preferred option if chronic immunosuppression was necessary. Steroids were given for a longer duration and tapered more gradually than inAbstract: Purpose: The Optic Neuritis Treatment Trial was a landmark study with implications worldwide. In the advent of antibody testing for neuromyelitis optica spectrum disease (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), emerging concepts, such as routine antibody testing and management, remain controversial, resulting mostly from studies in White populations. We evaluate the practice patterns of optic neuritis investigation and management by neuro-ophthalmologists and neurologists in Singapore. Design: 21-question online survey consisting of 4 clinical vignettes. Methods: The survey was sent to all Singapore Medical Council– registered ophthalmologists and neurologists who regularly manage patients with optic neuritis. Results: Forty-two recipients (17 formally trained neuro-ophthalmol-ogists [100% response rate] and 25 neurologists) responded. Participants opted for routine testing of anti–aquaporin-4 antibodies (88.1% in mild optic neuritis and 97.6% in severe optic neuritis). Anti-MOG antibodies were frequently obtained (76.2% in mild and 88.1% in severe optic neuritis). Plasmapheresis was rapidly initiated (85.7%) in cases of nonresponse to intravenous steroids, even before obtaining anti–aquaporin-4 or anti-MOG serology results. In both NMOSD and MOGAD, oral mycophenolate mofetil was the preferred option if chronic immunosuppression was necessary. Steroids were given for a longer duration and tapered more gradually than in idiopathic optic neuritis cases. Conclusions: Serological testing for NMOSD and MOGAD is considered as a routine procedure in cases of optic neuritis in Singapore, possibly due to local epidemiological features of these conditions. Chronic oral immunosuppression is preferred for the long term, but further research is necessary to establish the efficacy and cost-effectiveness of these practices. … (more)
- Is Part Of:
- Asia-Pacific journal of ophthalmology. Volume 11:Issue 2(2022)
- Journal:
- Asia-Pacific journal of ophthalmology
- Issue:
- Volume 11:Issue 2(2022)
- Issue Display:
- Volume 11, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 11
- Issue:
- 2
- Issue Sort Value:
- 2022-0011-0002-0000
- Page Start:
- 184
- Page End:
- 195
- Publication Date:
- 2022-03
- Subjects:
- myelin oligodendrocyte glycoprotein -- neuromyelitis optica -- optic neuritis
Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
Periodicals
617.7005 - Journal URLs:
- http://journals.lww.com/apjoo/pages/default.aspx ↗
http://ovidsp.tx.ovid.com/sp-3.15.1b/ovidweb.cgi?S=ODEGFPELAADDOHBGNCKKOHFBBKLOAA00&TOC=S.sh.22.23.28.29&journal_browse_filter=jp|318 ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/APO.0000000000000513 ↗
- Languages:
- English
- ISSNs:
- 0129-1653
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21421.xml